Vivek Subbiah, MD

Articles by Vivek Subbiah, MD

Overview of SCLC and Importance of Early Diagnosis

ByCharu Aggarwal, MD, MPH,Taofeek K. Owonikoko, MD, PhD,Charles M. Rudin, MD, PhD,Vivek Subbiah, MD,Jared Weiss, MD

June 27th 2022

Drs Owonikoko and Weiss provide a brief overview of small cell lung cancer and the vital importance of an early diagnosis to improve patient outcomes.

Vivek Subbiah, MD, discusses outcomes with selpercatinib in patients with RET fusion–positive cancer.

Dr. Subbiah on the Efficacy of Selpercatinib in RET Fusion–Positive Cancers

ByVivek Subbiah, MD

April 13th 2021

Vivek Subbiah, MD, discusses outcomes with selpercatinib in patients with RET fusion–positive cancer.

Vivek Subbiah, MD

Articles by Vivek Subbiah, MD

Overview of SCLC and Importance of Early Diagnosis

Dr. Subbiah on the Efficacy of Selpercatinib in RET Fusion–Positive Cancers

Trending on OncLive

ASCO Issues First Guideline on ctDNA Testing in Solid Tumors and Lymphoma

Dr Wainberg on INCB161734 Activity in Refractory Pancreatic Cancer

European Commission Approves Teclistamab Plus Daratumumab for R/R Myeloma

China’s NMPA Accepts NDA for Opamtistomig in Pretreated Advanced Extrapulmonary NEC

ESMO Guidelines Express Update Recommends Daraxonrasib for RAS G12–Mutated Metastatic PDAC